Skip to main content

Gelesis Holdings, Inc.

GLSHDelisted
Industry
Pharmaceutical Preparations
SEC CIK
0001805087

Gelesis Holdings, Inc. was delisted in 2023; its insiders filed their last Form 4 on Sep 21, 2023; no institution reported holding it in 13F filings for Q3 2023; no superinvestor held it.

Key figures

Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
0
Q3 2023, −2 vs. previous quarter
13F value
$0
Reported value at the end of Q3 2023
Superinvestors holding
0
At the end of Q3 2023

Superinvestors holding GLSH, Q3 2023

Go to the superinvestors tab

No superinvestor reported holding GLSH at the end of Q3 2023.

Latest insider trades

Open-market purchases and sales by Gelesis Holdings, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 21, 2023 (view filing)4:30 PM ETSep 201 dayPureTech Health LLC and 1 other10% OwnerPPurchase+30.4M–––DerivativePrice outlier
Jun 14, 2023 (view filing)4:30 PM ETJun 122 daysPureTech Health LLC and 1 other10% OwnerPPurchase+223.9M–––DerivativePrice outlier
May 31, 2023 (view filing)5:30 PM ETMay 265 daysPureTech Health LLC and 1 other10% OwnerPPurchase+67.8M–––43.1M afterDerivative2 lotsPrice outlier
May 3, 2023 (view filing)4:30 PM ETMay 12 daysPureTech Health LLC and 1 other10% OwnerPPurchase+344.5M$225,637.55+$29.0T–192.3M afterDerivative4 lotsPrice outlier
Nov 22, 2022 (view filing)6:20 PM ETNov 18-214 daysKucherlapati Raju SDirectorPPurchase+100.0K$0.4452+$44.5K+110.8%190.3K after2 lots
Jun 17, 2022 (view filing)Jun 152 daysKucherlapati Raju SDirectorPPurchase+24.6K$1.95+$48.0K+37.5%90.3K after
Jan 19, 2022 (view filing)Jan 145 daysKucherlapati Raju SDirectorPPurchase+15.0K$6.67+$100.0KNew position15.0K after

Top 10 13F holders, Q3 2023

The largest institutional positions in Gelesis Holdings, Inc. at the end of Q3 2023; share changes are against Q2 2023.

View all: Top 10 13F holders, Q3 2023

No institution reported holding GLSH in 13F filings for Q3 2023.